SCHEMBL23679552

SCHEMBL23679552

Nc1ncnc2c1ncn2[C@@H]1O[C@H](OP(=O)(O)S)CC1OP(=O)(S)OC[C@@H]1CC(=O)[C@H](n2c(=O)[nH]c3c(N)ncnc32)O1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ DTYMK P23919 2/20 0.42
▸ P2RY1 P47900 4/20 0.42
▸ P2RY2 P41231 3/20 0.42
▸ SRC P12931 2/20 0.42
▸ SMN1; SMN2 Q16637 2/20 0.42
▸ DNPH1 O43598 1/20 0.42
▸ PRKAB2 O43741 1/20 0.42
▸ TRPM2 O94759 1/20 0.42
▸ LDHA P00338 1/20 0.42
▸ ADRB2 P07550 1/20 0.42
▸ FBP1 P09467 1/20 0.42
▸ ADORA1 P30542 1/20 0.42
▸ PRKAG1 P54619 1/20 0.42
▸ PRKAA2 P54646 1/20 0.42
▸ PDE4D Q08499 1/20 0.42
▸ KCNH2 Q12809 1/20 0.42
▸ PRKAA1 Q13131 1/20 0.42
▸ PDE3A Q14432 1/20 0.42
▸ TAS1R3 Q7RTX0 1/20 0.42
▸ TAS1R1 Q7RTX1 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23679816 0.85 FHIT (0.44) P2RY1P2RY2SRCSMN1; SMN2DNPH1
SCHEMBL29331768 0.82 DTYMK (0.44) DTYMKP2RY1P2RY2SRCSMN1; SMN2
SCHEMBL21895700 0.80 POLB (0.52) DTYMKP2RY1P2RY2
SCHEMBL23679478 0.79 DTYMK (0.34) DTYMKP2RY1P2RY2SRCSMN1; SMN2
SCHEMBL21896050 0.79 DTYMK (0.47) DTYMKP2RY1P2RY2SRCSMN1; SMN2
SCHEMBL29324032 0.78 DTYMK (0.45) DTYMKP2RY1P2RY2SRCSMN1; SMN2
SCHEMBL29325792 0.77 RNASEL (0.48) P2RY1P2RY2SRCSMN1; SMN2DNPH1
SCHEMBL29325801 0.76 FHIT (0.44) DTYMKP2RY1P2RY2SRCSMN1; SMN2
SCHEMBL29325781 0.76 DTYMK (0.41) DTYMKP2RY1P2RY2SRCSMN1; SMN2
SCHEMBL23679635 0.75 P2RY1 (0.42) DTYMKP2RY1P2RY2SRCSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3854799-A1 CYCLIC DINUCLEOTIDE ANALOGUE, PHARMACEUTICAL COMPOSITION THEREOF, AND APPLICATION Shanghai de Novo Pharmatech Co., Ltd. (CN) 2021-07-28 — — EP disclosed
Send feedback